Pacira | PCRX - Trade Creditors


Pacira reported $15.15M in Trade Creditors for its fiscal quarter ending in December of 2025.





Trade Creditors Change Date
Assertio Holdings USD 14.66M 3.81M Sep/2025
Astellas Pharma JPY 199.75B 17.8B Mar/2026
Bristol-Myers Squibb USD 4.29B 1.14B Sep/2025
Cara Therapeutics USD 4.08M 1.65M Sep/2025
Coherus Biosciences USD 9.91M 14.98M Dec/2025
Heron Therapeutics USD 8.99M 3.02M Dec/2025
Ironwood Pharmaceuticals USD 1.61M 224K Sep/2025
J&J USD 10.46B 1.53B Mar/2026
Ligand Pharmaceuticals USD 3.24M 24.52M Dec/2025
Nektar Therapeutics USD 10.77M 4.79M Dec/2025
Novo Nordisk DKK 19.76B 4.15B Dec/2025
Omeros USD 8.84M 4.42M Jun/2025
Pacira USD 15.15M 2.54M Dec/2025
Perrigo USD 474.5M 4.8M Dec/2025
Pfizer USD 5.02B 142M Sep/2025
Supernus Pharmaceuticals USD 107.8M 813K Dec/2025
Teva Pharmaceutical Industries USD 2.53B 176M Dec/2025
Xeris Pharmaceuticals USD 3.08M 3.45M Dec/2025
Xoma USD 2.65M 1.52M Sep/2025
Zoetis USD 487M 77M Dec/2025